Pharmactive Biotech, S.L., is tapping into the pharmaceutical market with its leading branded ingredients, such as affron® saffron extract, for supporting mental health. The company has appointed Paul Clayton, PhD as Chair of its scientific advisory board. Together with Pharmactive’s medical advisor, Carlos Galmarini, MD, PhD, they will lead this strategic move for Pharmactive.
“Including high-level medical and natural science experts on the advisory board enables the company to combine and reconcile the two worlds of pharma and nutraceuticals, to benefit both consumers and medical practitioners and will help the pharmaceutical business provide greater value to their patrons,” says Jean-Marie Raymond, CEO at Pharmactive.
A clinical pharmacologist and pharmacological nutritionist, Paul Clayton works with leading doctors and clinical scientists at centers of clinical expertise in multiple countries, designing and supervising pre-clinical and clinical trials of pharmaco-nutritional interventions. As an advisor at Pharmactive, he will support strategic product development, advise in clinical studies protocols, and provide consumer insights. “Clayton will serve as the voice of the consumer and the nutraceutical industry using his extensive knowledge of natural pharmacology to bring an evidence-based, prevention-focused point of view to physicians,” adds Raymond.
Carlos Galmarini, the Founder and CEO of Topazium Smart Medicine, Spain, comes with profound experience. “An ingredient for mood health, such as Pharmactive’s validated saffron extract, affron, can be used as stand-alone or to enhance pharmaceutical products,” explains Clayton. “Consumers are seeking science-based, natural mental wellness solutions and Pharmactive can answer this demand, having already pioneered in the field. The company recently published a clinical study on affron with antidepressants, and there are more to come. An ingredient for mood health, such as Pharmactive’s validated saffron extract, affron, can be used as stand-alone or to enhance pharmaceutical products,” explains Clayton. “Consumers are seeking science-based, natural mental wellness solutions and Pharmactive can answer this demand, having already pioneered in the field. The company recently published a clinical study on affron with antidepressants, and there are more to come,” he added.
